903TiP - Preoperative olaparib in early-stage endometrial cancer (EC): A phase 0, window of opportunity trial to evaluate the PARP inhibition effect, targeting cell cycle-related proteins (POLEN study)
Autor: | Romero, I., Rubio, M.J., Serrano, R., Medina, M., Minig, L., Casado, A., Coronado, P., Martínez, S., Orbegoso, C., Fusté, P., Alia, E.M. Guerra, Sánchez-Martínez, M.C., Rubio, D., Santacana, M., Ruiz, M., Llombart-Cussac, A., Matias-Guiu, X., Poveda, A.M. |
---|---|
Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi312-vi312 |
Databáze: | ScienceDirect |
Externí odkaz: |